Cite
Capsid Inhibition with Lenacapavir in Multidrug-Resistant HIV-1 Infection.
MLA
Segal-Maurer, Sorana, et al. “Capsid Inhibition with Lenacapavir in Multidrug-Resistant HIV-1 Infection.” The New England Journal of Medicine, vol. 386, no. 19, May 2022, pp. 1793–803. EBSCOhost, https://doi.org/10.1056/NEJMoa2115542.
APA
Segal-Maurer, S., DeJesus, E., Stellbrink, H.-J., Castagna, A., Richmond, G. J., Sinclair, G. I., Siripassorn, K., Ruane, P. J., Berhe, M., Wang, H., Margot, N. A., Dvory-Sobol, H., Hyland, R. H., Brainard, D. M., Rhee, M. S., Baeten, J. M., & Molina, J.-M. (2022). Capsid Inhibition with Lenacapavir in Multidrug-Resistant HIV-1 Infection. The New England Journal of Medicine, 386(19), 1793–1803. https://doi.org/10.1056/NEJMoa2115542
Chicago
Segal-Maurer, Sorana, Edwin DeJesus, Hans-Jurgen Stellbrink, Antonella Castagna, Gary J Richmond, Gary I Sinclair, Krittaecho Siripassorn, et al. 2022. “Capsid Inhibition with Lenacapavir in Multidrug-Resistant HIV-1 Infection.” The New England Journal of Medicine 386 (19): 1793–1803. doi:10.1056/NEJMoa2115542.